-
-
Call more information
660-596-2224 -
Injecting a newer long-acting numbing medicine called liposomal bupivacaine into the tissue surrounding the knee during knee replacement surgery may provide a faster recovery and higher patient satisfaction. While improvements in implantable devices and surgical technique has made knee replacement surgery highly effective, pain control after surgery remains a common but persistent side effect for […]
Read MoreThe FDA drafted new recommendations regarding the fill size for vials of injectable drugs and biologic products this summer, which prompted a response from the American Society of Anesthesiologists. In a letter to FDA Commissioner Margaret Hamburg, ASA President Jane Fitch, MD, said the anesthesiology group “strongly supports the FDA’s recommendation that a drug product’s […]
Read MoreIf the experience of residents holds true for their more senior colleagues, then a pilot project at the State University of New York at Stony Brook has the potential to improve syringe labeling in more than one institution. A preprinted label system developed by residents Brian Cho, MD, and Kevin Lee, MD, received an overwhelmingly […]
Read MorePublished in BMC Anesthesiol. 2014;14(68) Authors: Hyoung Yong Moon et al A Double-Blind Randomised Trial Abstract Background Postoperative nausea and vomiting (PONV) is one of the most common postsurgical complications. Palonosetron, a 5-hydroxytryptamine receptor antagonist, is effective for PONV prevention. Herein, we compared palonosetron and aprepitant (a neurokinin-1 receptor antagonist) for PONV prevention in patients […]
Read MorePublished in Br J Anaesth. 2014;112(6):955-957. Authors: M. A. Shulman, et al Owing to increases in life expectancy, the patients presenting for surgery are older, and have more co-morbidities. Worldwide, 3–4% of patients die within 2 months of major surgery, with increased mortality and morbidity in high-risk surgical candidates, including the elderly and medically unwell. In Australia […]
Read More